Journal of Addiction Medicine · 2020 · 52 citations · 1 references
NursingPharmacologyPharmacotherapyBehavioral MedicinePsychopharmacologySubstance Use DisordersOpioid AnalgesicsOpioid ManagementOpioid PolicyOpioid TherapyOpioid Use DisorderSubstance Use Crisis ManagementBuprenorphine TreatmentMethadone Maintenance TherapyMethadone Maintenance TreatmentOpioid Use Disorder Treatment RetentionPatient-provider Communication BarriersSocial Isolation InterventionTake-home Dosing Rules
: The COVID-19 health crisis joined, rather than supplanted, the opioid crisis as the most acutely pressing threats to US public health. In the setting of COVID-19, opioid use disorder treatment paradigms are being disrupted, including the fact that methadone clinics are scrambling to give "take-home" doses where they would typically not. The rapid transition away from in-person examination, dosing and group therapy in an era of social isolation calls for adjustments to clinical practice, including emphasizing patient-provider communication, favoring new inductees on buprenorphine and leveraging technology to optimize safety of medication treatment.
1